Literature DB >> 24377725

Predictors of outcome in the non-operative management of thoracolumbar and lumbar burst fractures.

Patrick W Hitchon1, Wenzhuan He, Stephen Viljoen, Nader S Dahdaleh, Rajinder Kumar, Jennifer Noeller, James Torner.   

Abstract

AIM: Burst fractures without neurological deficit are often treated successfully without surgery. A subgroup may fail non-operative treatment owing to pain, and opt for surgery. The following review was conducted to identify predictors of success or failure in the non-operative treatment of thoracolumbar burst fractures.
METHODS: A cohort of 60 patients with T11-L4 thoracolumbar burst fractures were treated non-operatively, with bed rest and bracing until the pain abated sufficiently to allow mobilization. Patients were followed prospectively for a mean ± SD of 12 ± 14 months, and their data were reviewed retrospectively.
RESULTS: Fifty-one patients successfully completed non-operative treatment. Owing to intractable pain in nine, surgery was undertaken. Ages in the non-operative and operative groups were 46 ± 18 and 68 ± 15 years respectively (p = 0.002). The residual canal and angulation at the site of the fracture were 63 ± 12% and 1.6 ± 8.4° in the non-operative group and 47 ± 15% and 6.6 ± 13.6° in the surgical group (p = 0.001 and 0.149 between groups, respectively). Regression analysis of age, gender, angulation, and residual canal showed that only age (OR, 1.099; 95% CI, 1.022-1.183; p = 0.011) and residual canal (OR, 0.795; 95% CI, 0.642-0.985; p = 0.035) were significant predictors of failure, ultimately undergoing surgery.
CONCLUSION: Non-surgical treatment was more likely to prove sufficient in patients aged 46 ± 18 years, and residual canal of 63 ± 12%, than in older patients with ages of 68 ± 15, and canal of 47 ± 15%. The latter group was more likely to fail, undergoing surgery because of pain or instability.

Entities:  

Keywords:  burst; fractures; spinal instrumentation; spine fracture; thoracolumbar

Mesh:

Year:  2013        PMID: 24377725     DOI: 10.3109/02688697.2013.872226

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  6 in total

1.  [Treatment of trauma-related vertebral body fractures of the thoracic and lumbar spine with orthotic devices : A review].

Authors:  Philipp Georg Schnadthorst; Celine Lankes; Christoph Schulze
Journal:  Unfallchirurgie (Heidelb)       Date:  2022-07-18

2.  Functional Outcome of Surgical versus Conservative Therapy in Patients with Traumatic Thoracolumbar Fractures and Thoracolumbar Injury Classification and Severity Score of 4; A Non-randomized Clinical Trial.

Authors:  Mohsen Koosha; Hossein Nayeb Aghaei; Hamid Reza Khayat Kashani; Sepideh Paybast
Journal:  Bull Emerg Trauma       Date:  2020-04

3.  Rate and Predictors of Failure in the Conservative Management of Stable Thoracolumbar Burst Fractures: A Systematic Review and Meta-Analysis.

Authors:  Terence Tan; Milly S Huang; Joost Rutges; Travis E Marion; Mark Fitzgerald; Martin K Hunn; Jin Tee
Journal:  Global Spine J       Date:  2021-07-19

4.  Orthosis for thoracolumbar burst fractures without neurologic deficit: A systematic review of prospective randomized controlled trials.

Authors:  Gabriel Alcalá-Cerra; Angel J Paternina-Caicedo; Cindy Díaz-Becerra; Luis R Moscote-Salazar; Andrei Fernandes-Joaquim
Journal:  J Craniovertebr Junction Spine       Date:  2014-01

5.  Decision-Making Process in Patients with Thoracolumbar and Lumbar Burst Fractures with Thoracolumbar Injury Severity and Classification Score Less than Four.

Authors:  Shirzad Azhari; Parisa Azimi; Sohrab Shahzadi; Hassan Reza Mohammadi; Hamid Reza Khayat Kashani
Journal:  Asian Spine J       Date:  2016-02-16

6.  A new decompression technique for upper lumbar fracture with neurologic deficit-comparison with traditional open posterior surgery.

Authors:  Bangke Zhang; Fengjin Zhou; Liang Wang; Haibin Wang; Jiayao Jiang; Qunfeng Guo; Xuhua Lu
Journal:  BMC Musculoskelet Disord       Date:  2019-12-01       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.